The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome

Journal of Clinical Investigation

Volumn 114, Issue 11, 2004, Pages 1659-1665

  Godschalk, Peggy C R ^a   Heikema, Astrid P ^a   Gilbert, Michel ^b   Komagamine, Tomoko ^c   Wim Ang, C ^a   Glerum, Jobine ^a   Brochu, Denis ^b   Li, Jianjun ^b   Yuki, Nobuhiro ^c   Jacobs, Bart C ^a   Van Belkum, Alex ^a   Endtz, Hubert P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; OLIGOSACCHARIDE; SIALIC ACID; AUTOANTIBODY; BIOLOGICAL MARKER; LIPID LINKED OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; LIPOPOLYSACCHARIDE; N ACETYLNEURAMINIC ACID;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; CROSS REACTION; GENE LOCUS; GUILLAIN BARRE SYNDROME; HUMAN; MARKER GENE; MOLECULAR MIMICRY; MOUSE; MUTANT; NERVOUS TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYNEUROPATHY; PRIORITY JOURNAL; SIALYLATION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; CONFORMATION; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS; MUTATION;

ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CAMPYLOBACTER JEJUNI; CARBOHYDRATE CONFORMATION; CROSS REACTIONS; GANGLIOSIDES; GENES, BACTERIAL; GUILLAIN-BARRE SYNDROME; HUMANS; LIPOPOLYSACCHARIDES; MICE; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; MUTATION; N-ACETYLNEURAMINIC ACID;

EID: 14644435916     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200415707     Document Type: Article

References (37)

1. Albert, L.J., and Inman, R.D. 1999. Molecular mimicry and autoimmunity. N. Engl. J. Med. 341:2068-2074.
2. Ang, C.W., Jacobs, B.C., and Laman, J.D. 2004. The Guillain-Barré syndrome: a true case of molecular mimicry. Trends Immunol 25:61-66.
3. Yuki, N. 2001. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes. Lancet Infect. Dis. 1:29-37.
4. Jacobs, B.C., et al. 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 51:1110-1115.
5. Lecuit, M., et al. 2004. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N. Engl. J. Med. 350:239-248.
6. Willison, H.J., and Yuki, N. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 125:2591-2625.
7. Moran, A.P. 1997. Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. J. Infect. Dis. 176(Suppl. 2):S115-S121.
8. Ang, C.W., et al. 2002. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect. Immun. 70:1202-1208.
9. Moran, A.P., Rietschel, E.T., Kosunen, T.U., and Zahringer, U. 1991. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J. Bacteriol. 173:618-626.
10. Endtz, H.P., et al. 2000. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. J. Clin. Microbiol. 38:2297-2301.
11. Fisher, M. 1956. An unusual variant of acute idiopathic polyneuritis: syndrome of ophthalmoplegia, ataxia and areflexia. N. Engl. J. Med. 255:57-65.
12. Dingle, K.E., et al. 2001. Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller Fisher syndromes are of diverse genetic lineage, serotype and flagella type. J. Clin. Microbiol. 39:3346-3349.
13. van Belkum, A., et al. 2001. A Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat. Med. 7:752-753.
14. Linton, D., Karlyshev, A.V., and Wren, B.W. 2001. Deciphering Campylobacter jejuni cell surface interactions from the genome sequence. Curr. Opin. Microbiol. 4:35-40.
15. Gilbert, M., et al. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 277:327-337.
16. 13C NMR analysis. J. Biol Chem. 275:3896-3906.
17. Gilbert, M., et al. 2004. Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchange. Infect. Immun. 72:1162-1165.
18. Lunn, M.P.T., et al. 2000. High-affinity antiganglioside IgG antibodies raised in complex ganglioside knockout mice. Reexamination of GD1a immunolocalization. J. Neurochem. 75:404-412.
19. Parkhill, J., et al. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature. 403:665-668.
20. Chiba, A., Kusunoki, S., Obata, H., Machinami, R., and Kanazawa, I. 1993. Serum anti-GQ1bIgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 43:1911-1917.
21. Guerry, P., et al. 2002. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect. Immun. 70:787-793.
22. Prendergast, M.M., et al. 2004. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection. Infect. Immun. 72:916-922.
23. Leonard, E.E., II, Tompkins, L.S., Falkow, S., and Nachamkin, I. 2004. Comparison of Campylobacter jejuni isolates implicated in Guillain-Barré syndrome and strains that cause enteritis by a DNA microarray. Infect. Immun. 72:1199-1203.
24. Chiu, C.P., et al. 2004. Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog. Nat. Struct. Mol. Biol. 11:163-170.
25. Guerry, P., Ewing, C.P., Hickey, T.E., Prendergast, M.M., and Moran, A.P. 2000. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect. Immun. 68:6656-6662.
26. Linton, D., et al. 2000. Multiple N-acetyl neuraminic acid synthetase (neuB) genes in Campylobacter jejuni: identification and characterization of the gene involved in sialylation of lipo-oligosaccharide. Mol. Microbiol 35:1120-1134.
27. Bowes, T., et al. 2002. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect. Immun. 70:5008-5018.
28. Yuki, N., et al. 2001. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside. Ann. Neurol. 49:712-720.
29. Jacobs, B.C., et al. 1996. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40:181-187.
30. Willison, H.J., et al. 2004. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 127:680-691.
31. Ang, C.W., et al. 2000. A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis. J. Neuroimmunol. 111:229-233.
32. Wren, B.W., Henderson, J., and Ketley, J.M. 1994. A PCR-based strategy for the rapid construction of defined bacterial deletion mutants. Biotechniques. 16:994-996.
33. van Vliet, A.M., Wooldridge, K.G., and Ketley, J.M. 1998. Iron-responsive gene regulation in a Campylobacter jejuni fur mutant. J. Bacteriol. 180:5291-5298.
34. Szymanski, C.M., et al. 2003. Detection of conserved N-linked glycans and phase-variable lipooligosaccharides and capsules from Campylobacter cells by mass spectrometry and high resolution magic angle spinning NMR spectroscopy. J. Biol. Chem. 278:24509-24520.
35. St. Michael, F., et al. 2002. The structures of the lipooligosaccharide and capsule polysaccharide of Campylobacter jejuni genome sequenced strain NCTC 11168. Eur. J. Biochem. 269:5119-5136.
36. Takamiya, K., et al. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. U. S. A. 93:10662-10667.
37. Yuki, N., Tagawa, Y., Irie, F., Hirabayashi, Y., and Handa, S. 1997. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha. J. Neuroimmunol. 74:30-34.